LS
Laura Sutcliffe UBS Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
ResMed
RMD
$40.6B
| $277.05 | $325 |
17%
upside
| Buy | 1 month ago |
|
2 |
TLX
2
Telix Pharmaceuticals Limited American Depositary Shares
TLX
$3.03B
| $9.06 | $22 |
143%
upside
| Buy | 7 months ago |
|
3 |
3
argenx
ARGX
$45.9B
| $750.78 | $390 |
48%
downside
| Buy | 4 years ago |
|